Disclaimer

BEFORE ACCESSING THE INFORMATION PUBLISHED ON THE NEXT PAGES WE KINDLY ASK YOU TO THOROUGHLY READ THE FOLLOWING INFORMATION. BY CLICKING THE “ACCEPT” BUTTON BELOW, YOU CONFIRM THAT YOU READ THE INFORMATION BELOW, FULLY UNDERSTOOD IT AND THAT YOU AGREE ON THE LIMITATIONS INDICATED THEREIN.

The materials to which you will obtain access pertain to or are connected with the public offering of shares (the „Offer Shares”) of the company under business name Milestone Medical Inc. with its registered seat at 425 Eagle Rock Ave, Roseland, NJ 07068 USA (the „Company”) and cover the public offering of the newly issued shares of the Company (the “Offering”),seeking for the admission and introducing to the trading on regulated market maintained by the Warsaw Stock Exchange in Warsaw of the Company’s securities (the “Admission”).

As of December 4, 2015 the Polish Financial Supervision Authority approved the Company’s prospectus (the “Prospectus”) prepared in relation to the Public Offering and the Admission.

The Prospectus and potential annexes and updating communication to the Prospectus was published and is available, and within the period of its validity will be available in an electronic form on the Company’s website (www.medicalmilestone.com) as well as on the website of the Offering Agent – Vestor Dom Maklerski S.A. (www.vestor.pl). The Prospectus is the only legally binding offering document containing, for the purpose of the Offering and Admission, information regarding the Company, Offered Shares and the Offering.

The materials published on this website cover the Prospectus, potential annexes and updating communication to the Prospectus as well as, potentially, the information of promotional or advertising character that are used for the purpose of the Offering and the Admission. The materials published on this website do not constitute the offer within the meaning of the Polish Code of Civil Law or the Act on Public Offer and Conditions of Introducing Financial Instruments to the Organized Public Trading and Public Companies.

The following materials and information do not constitute an offer of sale of the securities in the United States of America, Canada, Japan, Australia or any other jurisdiction where such offer would constitute infringement of the relevant law or required registration. The securities cannot be sold within the United States of America unless registered by United States Securities and Exchange Commission or are subject to exemption from the registration duty on the grounds of relevant provisions of U.S. Securities Act of 1933. The Company’s securities were not and will not be registered pursuant to the provisions of U.S. Securities Act of 1933 and cannot be offered or disposed of within the territory of the United States of America, otherwise than as an exemption from registration requirement resulting from the U.S. Securities Act of 1933.

Neither the Prospectus nor the securities considered therein were not and will not be subject to registration, admission or notification in any other country outside the Republic of Poland, in particular pursuant to the provisions of law enacted under the Directive 2003/71/EC of the European Parliament and of the Council with further amendments, and cannot be offered or sold outside the borders of the Republic of Poland (including other countries of the European Union, United States of America, Canada, Japan and Australia), unless in the particular country such offer or sale could be performed in accordance with law, without the necessity of fulfilling any other additional legal requirements by the Company, Selling Shareholder and their advisors. Any investor living or having its seat outside the Republic of Poland should acquaint with the applicable provisions of Polish law and provisions of other countries that may be applicable in relation to its participation in the Offering.

By choosing the „ACCEPT” button below, you confirm that you stay within the territory of Poland. Obtaining access and acquainting with the content of the documents published on the next pages in contravention of the foregoing statement may constitute an infringement of the binding provisions concerning trading securities in certain jurisdictions.

I hereby accept the terms and conditions established herein.